BOT 1.43% 34.5¢ botanix pharmaceuticals ltd

nothofagus is saying that they won't announce starting Ph3...

  1. 289 Posts.
    lightbulb Created with Sketch. 92
    nothofagus is saying that they won't announce starting Ph3 trials for BTX1503, until the royalties from the current sales of SB in Japan are received.

    There are not any trials being undertaken in Japan.

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.